Sales rise 3.45% to Rs 36.89 crore
Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 2024 as against Rs 5.40 crore during the previous quarter ended December 2023. Sales rose 3.45% to Rs 36.89 crore in the quarter ended December 2024 as against Rs 35.66 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales36.8935.66 3 OPM %23.9420.16 -PBDT10.308.47 22 PBT9.527.84 21 NP6.515.40 21Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content